The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied

Thrombosis Research

Volumn 118, Issue 4, 2006, Pages 523-528

  Moore, Gary W ^a   Savidge, Geoffrey F ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Dilution effect; Lupus anticoagulant; Mixing studies; Reference ranges

Indexed keywords

LUPUS ANTICOAGULANT; SNAKE VENOM;

ANTICOAGULATION; ARTICLE; ASSAY; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SCREENING TEST; THROMBOSIS;

BLOOD COAGULATION TESTS; HUMANS; LUPUS COAGULATION INHIBITOR; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33747879160     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.09.010     Document Type: Article

References (21)

1. Arnout J. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thromb Haemost 86 (2001) 83-91
2. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74 (1995) 1185-1190
3. Greaves M., Cohen H., Machin S.J., and Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109 (2000) 704-715
4. Triplett D.A. Use of the dilute Russell Viper venom time (dRVVT): its importance and pitfalls. J Autoimm 15 (2000) 173-178
5. Alving B.M., Barr C.F., Johansen L.E., and Tang T.B. Comparison between a one-point dilute phospholipid APTT and the dilute Russell Viper Venom Time for verification of lupus anticoagulants. Thromb Haemost 67 (1992) 672-678
6. Moore G.W., Smith M.P., Patel Y., and Savidge G.F. The activated seven lupus anticoagulant (ASLA) assay: a new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway based assays. Blood Coagul Fibrinolysis 13 (2002) 261-269
7. Moore G.W., Smith M.P., and Savidge G.F. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinised patients with lupus anticoagulants. Blood Coagul Fibrinolysis 14 (2003) 307-312
8. Machin S.J., Giddings J.C., Greaves M., Hutton R.A., Mackie I.J., Malia R.G., et al. Guidelines on testing for the lupus anticoagulant. J Clin Pathol 44 (1991) 885-889
9. Gardiner C., Mackie I.J., Malia R.G., Jones D.W., Winter M., Leeming D., et al. The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant. Br J Haematol 111 (2000) 1230-1235
10. Moore G.W., Rangarajan S., Holland L.J., Henley A., and Savidge G.F. Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy. Br J Biomed Sci 62 (2005) 15-18
11. Male C., Lechner K., Speiser W., and Pabinger I. Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features. Thromb Haemost 83 (2000) 174-175
12. Thom J., Ivey L., and Eikelboom J. Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant. J Thromb Haemost 1 (2003) 2689-2691
13. Clyne L.P., Yen Y., Kriz N.S., and Breitenstein M.G. The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive population. Arch Pathol Lab Med 117 (1993) 595-601
14. Moore G.W., Savidge G.F., and Smith M.P. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time. Blood Coagul Fibrinolysis 11 (2000) 767-774
15. Triplett D.A. New diagnostic strategies for lupus anticoagulant and antiphospholipid antibodies. Haemostasis 24 (1994) 155-164
16. Kaczor D.A., Bickford N.N., and Triplett D.A. Evaluation of different mixing study reagents and dilution effect in lupus anticoagulant testing. Am J Clin Pathol 95 (1991) 408-411
17. Jouhikainen T. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy. Blood Coagul Fibrinolysis 1 (1990) 627-632
18. Stevenson K.J., and Sneddon J.M. The role of lipids in the detection of lupus anticoagulant by the dilute Russell Viper venom test: are platelets or reagents containing hexagonal HII phases necessary?. Br J Haematol 86 (1994) 583-589
19. Clyne L.P., and White P.F. Time dependency of lupus-like anticoagulants. Arch Intern Med 148 (1988) 1060-1063
20. Exner T. Conceptions and misconceptions in testing for lupus anticoagulants. J Autoimmun 15 (2000) 179-183
21. Jennings I., Greaves M., Mackie I.J., Kitchen S., Woods T.A., and Preston F.E. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 119 (2002) 364-369